Try a new search

Format these results:

Searched for:

school:SOM

Department/Unit:Plastic Surgery

Total Results:

5786


Advancing population health in the Harlem Children's Zone Project [Editorial]

Northridge, Mary E; Jean-Louis, Betina; Shoemaker, Katherine; Nicholas, Stephen
PMID: 12415919
ISSN: 0303-8408
CID: 160828

Preventing falls at home: Transforming unsafe spaces into healthy places for older people

Northridge, ME; Levick, N
ISI:000185520600009
ISSN: 0738-7806
CID: 1791112

Health and human rights [Editorial]

Northridge, ME
ISI:000172412100008
ISSN: 0090-0036
CID: 3828642

Comparison of the costs of DIEP and TRAM flaps [Letter]

Allen, R J
PMID: 11743435
ISSN: 0032-1052
CID: 721772

The pathogenesis of craniosynostosis in the fetus

Warren, S M; Longaker, M T
Craniosynostosis occurs in approximately 1:2000 live births. It may affect the coronal, sagittal, metopic and lambdoid sutures in isolation or in combination. Although non-syndromic synostoses are more common, over 150 genetic syndromes have been identified. Recent advances in genetic mapping have linked chromosomal mutations with craniosynostotic syndromes. Despite the identification of these genetic mutations, the fundamental biomolecular mechanisms mediating cranial suture biology remain unknown. Today, many laboratories are investigating murine cranial suture biology as a model for human cranial suture development and fusion. Normal murine cranial suture biology is very complex, but evidence suggests that the dura mater provides the biomolecular blueprints (e.g. the soluble growth factors), which guide the fate of the pleuripotent osteogenic fronts. While our knowledge of these dura-derived signals has increased dramatically in the last decade, we have barely begun to understand the fundamental mechanisms that mediate cranial suture fusion or patency. Interestingly, recent advances in both premature human and programmed murine suture fusion have revealed unexpected results, and have generated more questions than answers
PMID: 11754148
ISSN: 0513-5796
CID: 106158

Litigation, legislation, and ethics: opportunity for a better outcome

Jerrold, L
PMID: 11742314
ISSN: 0889-5406
CID: 1993212

Associations between severity of clefting and maxillary growth in patients with unilateral cleft lip and palate treated with infant orthopedics

Peltomaki T; Vendittelli BL; Grayson BH; Cutting CB; Brecht LE
OBJECTIVE: The purpose of this study was to examine possible associations between severity of clefting in infants and maxillary growth in children with complete unilateral cleft lip and palate. DESIGN: This was a retrospective study of measurements made on infant maxillary study casts and maxillary cephalometric variables obtained at 5 to 6 years of follow-up. SETTING: The study was performed at the Institute of Reconstructive Plastic Surgery of New York University Medical Center, New York, New York. PATIENTS: Twenty-four consecutive nonsyndromic unilateral complete cleft lip and palate patients treated during the years 1987 to 1994. INTERVENTIONS: All the patients received uniform treatment (i.e., presurgical orthopedics followed by gingivoperiosteoplasty to close the alveolar cleft combined with repair of the lip and nose in a single stage at the age of 3 to 4 months). Closure of the palate was performed at the age of 12 to 14 months. RESULTS: Infant maxillary study cast measurements correlated in a statistically significant manner with maxillary cephalometric measurements at age 5 to 6 years. CONCLUSIONS: The results demonstrate the large variation in the severity of unilateral cleft lip and palate deformity at birth. Patients with large clefts and small arch circumference, arch length, or both demonstrated less favorable maxillary growth than those with small clefts and large arch circumference or arch length at birth
PMID: 11681991
ISSN: 1055-6656
CID: 33289

Repair of a critical size defect in the rat mandible using allogenic type I collagen

Saadeh, P B; Khosla, R K; Mehrara, B J; Steinbrech, D S; McCormick, S A; DeVore, D P; Longaker, M T
Mandibular fractures, resulting from either trauma or reconstructive surgery, can be challenging craniofacial problems. The morbidity of failed fracture healing is significant and may require bone grafting. Donor site morbidity and finite amounts of autogenous bone are major drawbacks of autogenous bone grafting. Similarly, the use of allografts and xenografts may be associated with an increased risk of rejection, infection, and nonunion. To circumvent the limitations of bone grafting, research efforts have focused on formulating a suitable bone substitute. The purpose of our study was to evaluate the efficacy of type I collagen implants in repairing critical sized mandibular defects in rats. Twelve male Sprague-Dawley rats (200-300g) were divided equally into control and experimental groups. Full thickness, round, four millimeter in diameter defects were created in the ramus of the right mandible of all rats using an electrical burr at low speed. The defects were irrigated of all bone chips, and either filled with a precisely fitted disk of allogenic collagen type I gel (experimental animals) or left empty (control animals). Animals were killed 6 weeks after surgery and healing of the bone defects was assessed in a blinded fashion using radiologic and histologic analysis. Radiologic analysis of the control group revealed a clear circular right mandibular defect in all animals, whereas the collagen disk implant group revealed an indistinct to nonexistent right mandibular defect in all animals. Densitometric analysis revealed a significant difference between these groups (* P = 0.01). Similarly, gross analysis of control mandibles revealed a 4mm round, soft-tissue filled defect, while implanted defects demonstrated gross bone spanning the defect. Finally, histologic analysis of all control mandibles revealed clearly demarcated bony edges at the defect border with connective tissue spanning the defect. In contrast, histological analysis of all implanted mandibles revealed indistinct bony edges at the defect border with a thin layer of osteoblasts and viable bone spanning the defects. We have demonstrated the ability of type I collagen to promote healing of a membranous bony defect that would not otherwise heal at 6 weeks. The suitability of type I collagen as a carrier matrix provides ample opportunity for tissue-engineered approaches to further facilitate bony defect healing. Promoting bone formation through tissue engineering matrices offers great promise for skeletal healing and reconstruction.
PMID: 11711826
ISSN: 1049-2275
CID: 1430082

Litigation, Legislation, and Ethics. Consultation liability

Jerrold, L
PMID: 11709676
ISSN: 0889-5406
CID: 1993222

I am not alone [Editorial]

Zide BM
PMID: 11711973
ISSN: 0032-1052
CID: 63402